Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Length of Stay for Hospitalized Patients Treated with Ibrutinib or Bendamustine First-Line Therapy for Treatment of Chronic Lymphocytic Leukemia

Debra Irwin, Erika Szabo, Ashutosh Pathak, Boxiong Tang, MD PhD

Blood (2017) 130 (Supplement 1): 5618.

https://doi.org/10.1182/blood.V130.Suppl_1.5618.5618

Published: 2017

Journal Articles

Differences in Healthcare Utilization in CLL Patients Treated with BR Versus FCR

Susan Gabriel, Erika Szabo, Francesco Lo-Coco, Jifang Zhou, Boxiong Tang, Ashutosh Pathak

Blood (2016) 128 (22): 2406.

https://doi.org/10.1182/blood.V128.22.2406.2406

Published: 2016

Journal Articles

Budget Impact Analysis of Treating Chemotherapy Patients with Health Care Provider-Administered Tbo-Filgrastim, Filgrastim-Sndz, and Filgrastim in the United States

Holly Trautman, Erika Szabo, Francesco Lo-Coco, Elizabeth James, Susan Gabriel, Jifang Zhou, Ashutosh Pathak, Boxiong Tang

Blood (2016) 128 (22): 2407.

https://doi.org/10.1182/blood.V128.22.2407.2407

Published: 2016

Journal Articles

Long-Term Safety Experience with Bendamustine for Injection in a Real-World Setting

Peter Martin, MD, Paul Barr, MD, Brad S. Kahl, MD, Ashutosh Pathak

Blood (2016) 128 (22): 5591.

https://doi.org/10.1182/blood.V128.22.5591.5591

Published: 2016

Journal Articles

Budget Impact Analysis of Treating Chemotherapy Patients with Patient-Administered Tbo-Filgrastim, Filgrastim-Sndz, and Filgrastim in the United States

Holly Trautman, Erika Szabo, Francesco Lo-Coco, Elizabeth James, Susan Gabriel, Jifang Zhou, Ashutosh Pathak, Boxiong Tang

Blood (2016) 128 (22): 4786.

https://doi.org/10.1182/blood.V128.22.4786.4786

Published: 2016

Journal Articles

Real-World Safety Experience for Short-Acting Recombinant Human Granulocyte Colony-Stimulating Factor

Camille N Abboud, Nicole Lang, Andreas Lammerich, Anton Buchner, Patrick Liu, Udo Mueller, Ashutosh Pathak

Blood (2016) 128 (22): 2504.

https://doi.org/10.1182/blood.V128.22.2504.2504

Published: 2016

Journal Articles

Long-Term Safety Experience with Arsenic Trioxide in Patients with Acute Promyelocytic Leukemia

Martin S. Tallman, Francesco Lo-Coco, Ashutosh Pathak

Blood (2016) 128 (22): 4034.

https://doi.org/10.1182/blood.V128.22.4034.4034

Published: 2016

NARROW

Length of Stay for Hospitalized Patients Treated with Ibrutinib or Bendamustine First-Line Therapy for Treatment of Chronic Lymphocytic Leukemia

Differences in Healthcare Utilization in CLL Patients Treated with BR Versus FCR

Budget Impact Analysis of Treating Chemotherapy Patients with Health Care Provider-Administered Tbo-Filgrastim, Filgrastim-Sndz, and Filgrastim in the United States

Long-Term Safety Experience with Bendamustine for Injection in a Real-World Setting

Budget Impact Analysis of Treating Chemotherapy Patients with Patient-Administered Tbo-Filgrastim, Filgrastim-Sndz, and Filgrastim in the United States

Real-World Safety Experience for Short-Acting Recombinant Human Granulocyte Colony-Stimulating Factor

Long-Term Safety Experience with Arsenic Trioxide in Patients with Acute Promyelocytic Leukemia

Email alerts

ASH Publications

American Society of Hematology

Length of Stay for Hospitalized Patients Treated with Ibrutinib or Bendamustine First-Line Therapy for Treatment of Chronic Lymphocytic Leukemia

Differences in Healthcare Utilization in CLL Patients Treated with BR Versus FCR

Budget Impact Analysis of Treating Chemotherapy Patients with Health Care Provider-Administered Tbo-Filgrastim, Filgrastim-Sndz, and Filgrastim in the United States

Long-Term Safety Experience with Bendamustine for Injection in a Real-World Setting

Budget Impact Analysis of Treating Chemotherapy Patients with Patient-Administered Tbo-Filgrastim, Filgrastim-Sndz, and Filgrastim in the United States

Real-World Safety Experience for Short-Acting Recombinant Human Granulocyte Colony-Stimulating Factor

Long-Term Safety Experience with Arsenic Trioxide in Patients with Acute Promyelocytic Leukemia

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only